Hepatitis B virus infection [1] (multiple letters)

TL;DR: It is proposed that HBV replication is modulated differently in the different stages of cell growth, and can be divided into three phases (initial proliferation phase, exponential proliferation phase and growth confluency phase) according to the cell growth curve.

TL;DR: It is necessary as a country to integrate hepatitis B counselling into the already existing HIV structures in the health delivery system to offer support for individuals diagnosed with hepatitis B, showed the findings of the study.

TL;DR: M maternal chronic hepatitis B (CHB) prevalence and infant infection during the first year of life within a cohort of women living with HIV is described.

TL;DR: It is shown that abnormal levels of hepatic fatty acids increase HBx protein stability during HBV expression, resulting in the potentiation of HBx‐induced inflammation, indicating that different fatty acid levels in the liver might affect HBV‐induced pathogenesis.

TL;DR: It is suggested that the competence of the cell-mediated (T-lymphocyte-dependent) immune system would decide whether the infection is self-limited or persists with varying degrees of liver damage.

TL;DR: The evidence is strengthened for a significant effect of HIV infection on the natural history of chronic HBV infection, which by prolonging the period of infectivity could have an important impact on the epidemiology ofHBV infection in regions, or patient groups, with high HIV seroprevalence.

TL;DR: Results show that vigorous anti-viral T cell responses are detectable in vitro several years after clinical recovery from acute hepatitis B, suggesting that long-term maintenance of an active anti-Viral Tcell response could be important not only for protection against reinfection but also for keeping the persisting virus under tight control.

TL;DR: The findings do underscore the clinical relevance of HBV infection in the absence of serological markers, and may underscore the need to further investigate the origin of such infections in patients in a California transplantation programme.